The parietal cells of the stomach produce gastric acid that is essential for the digestion
of food to provide nutrient availability for organ and muscle use. Excessive gastric
juice production can lead to lesions in the gastric mucosa, resulting in ulcers. The rate
and concentration of acid secretion are influenced by factors such as food,
medications, and chronic diseases. This research was carried out to assess the role
gastric ulcer plays in acid production or secretion. The research further examined
how Musa paradisiaca extracts and fractions influence gastric acid in ulcer conditions.
Sixty rats were divided into twelve groups: Groups A and B served as the control
groups administered 10 mL/kg of distilled water; Groups C – E were induced with
ulcer and administered with 48.99, 97.98, and 146.97 mg/kg Musa paradisiaca ethanol
extracts; Groups F – I were induced with ulcer and administered with 97.98 mg/kg
Musa paradisiaca fractions; Group J received 0.29 mg/kg omeprazole; Group K was
given 5.71 mg/kg cimetidine; and Group L received 97.98 mg/kg aqueous Musa
paradisiaca extract. The administration was oral and lasted for 28 days. On the last
day, the animals were sacrificed after being anaesthetized with ketamine
hydrochloride intraperitoneally, the stomach excised, and contents of the stomach
removed for titratable acidity analysis. The obtained data were statistically analysed.
The results showed that the presence of gastric lesions, acid volume, concentration,
secretion rate, and basal output were substantially reduced as the immune system
regulated acid production to defend the mucosa and limit exposure to its harsh
effects. In conclusion, the aqueous extract and fractions of Musa paradisiaca peels
demonstrated more potency than omeprazole and cimetidine in regulating gastric
acid production and secretion in gastric ulcer conditions and promoting healing.
          
          
          Keywords: Musa paradisiaca peels, gastric ulcer, gastric acid secretion, stomach,
cimetidine.
          
